Craft

Samil Pharmaceutical

Stock Price

₩15.8 K

2024-10-29

Market Capitalization

₩320.9 B

2024-10-29

Revenue

₩219.7 B

FY, 2024

Samil Pharmaceutical Summary

Company Summary

Overview
Samil Pharmaceutical (삼일제약주) is a manufacturer and supplier of medical devices and pharmaceutical products. It offers prescription and over-the-counter drugs, medical equipment, healthcare supplements, quasi-drugs, general medicines, and other products.
Type
Public
Status
Active
Founded
1947
HQ
KR | view all locations
Website
http://www.samil-pharm.com
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Seoul HQ

    Korea (Republic of)

    155 Hyoryeong-ro, Seocho-gu

Samil Pharmaceutical Financials

Summary Financials

Revenue (Q3, 2025)
₩51.2B
Gross profit (Q3, 2025)
₩19.5B
Net income (Q3, 2025)
(₩7.9B)
Cash (Q3, 2025)
₩6.5B
EBIT (Q3, 2025)
(₩5.3B)
Enterprise value
$478.8B

Footer menu